Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth
SEATTLE, March 11, 2013
SEATTLE, March 11, 2013 /PRNewswire/ --Cell Therapeutics, Inc. (CTI) (NASDAQ
and MTA: CTIC) today announced that management will present at the ROTH
Capital Partners 25^th Annual Growth Stock Conference on Monday, March 18, at
2:30 p.m. Pacific/ 5:30 p.m. Eastern/ 10:30 p.m. Central European time at the
Ritz-Carlton Laguna Niguel in Dana Point, CA.
The presentation will also be webcast live and available for replay after the
presentation. The webcast can be accessed at www.celltherapeutics.com.
About Cell Therapeutics, Inc.
Cell Therapeutics (NASDAQ and MTA: CTIC) is a biopharmaceutical company
committed to the development and commercialization of an integrated portfolio
of oncology products aimed at making cancer more treatable. CTI is
headquartered in Seattle, WA. For additional information and to sign up for
email alerts and get RSS feeds, please visit the company's website at
SOURCE Cell Therapeutics, Inc.
Press spacebar to pause and continue. Press esc to stop.